FDA Orange Book
Generic for Pipracil
Pipracil contains piperacillin. Orange Book status for every listed strength, the approved generic makers, and the listed patents and exclusivities.
Source: FDA Orange Book data file dated 2026-10-09. Publisher page
Yes. The generic name for Pipracil is piperacillin. 1 company holds an active FDA approval (ANDA) for a generic version in the Orange Book.
Run it in Rivvi
Map Pipracil and your other top fills to their generics
Every strength in RxNorm, with brands that have no generic flagged.
Build the mapFree to start. Opens Rivvi, the AI workspace for healthcare teams.
Pipracil products in the Orange Book
| Form and route | Strength | Brand status | Brand TE | Active generics | Generic TE codes |
|---|---|---|---|---|---|
| injectable, injection | EQ 2GM BASE/VIAL | Discontinued | None | 1 | None |
| injectable, injection | EQ 3GM BASE/VIAL | Discontinued | None | 1 | None |
| injectable, injection | EQ 40GM BASE/VIAL | Discontinued | None | 1 | None |
| injectable, injection | EQ 4GM BASE/VIAL | Discontinued | None | 1 | None |
NDA 050545, held by WYETH PHARMACEUTICALS INC. Active generics are ANDA products in the Orange Book prescription list with the same ingredient, dosage form, route and strength.
Approved generic piperacillin
| Company | ANDA | TE code | Approved | Strengths |
|---|---|---|---|---|
| ACS DOBFAR SPA | 065114 | None (No TE code listed) | November 14, 2003 | EQ 2GM BASE/VIAL, EQ 3GM BASE/VIAL, EQ 4GM BASE/VIAL |
| ACS DOBFAR SPA | 065157 | None (No TE code listed) | July 12, 2004 | EQ 40GM BASE/VIAL |
Questions
Is there a generic for Pipracil?
Yes. The generic name for Pipracil is piperacillin. 1 company holds an active FDA approval (ANDA) for a generic version in the Orange Book.
What is the generic name for Pipracil?
The active ingredient in Pipracil is piperacillin, per the FDA Orange Book.
What does a therapeutic equivalence code mean?
In the Orange Book, codes that start with A (such as AB) mean FDA considers the product therapeutically equivalent to the reference drug. Codes that start with B mean FDA does not, at this time, consider the product therapeutically equivalent.